Allergies are becoming more common in the United States. According to the Centers for Disease Control and Prevention's National Center for Health Statistics, nearly 1 in 3 adults and over 1 in 4 ...

Allergies are becoming more common in the United States. According to the Centers for Disease Control and Prevention’s National Center for Health Statistics, nearly 1 in 3 adults and over 1 in 4 ...

July 24, 2025 – The FDA has approved a new treatment as the first and only skin cream for a specific type of hand eczema that affects about 1 in every 10 people globally. The cream, sold under the ...

Gogglebox returned for its new series on Friday night, going strong after 12 years on Channel 4. There were some big changes for the 26th outing, with five new families announced to be joining the ...

Despite hitting its efficacy targets in the Phase III COAST-1 study, Sanofi’s amlitelimab remains “meaningfully inferior” to Dupixent, according to analysts at Leerink Partners. Sanofi’s ...

If you’re looking for a new cosy jumper which is also full of personality, then the Natalie Embroidered Jumper at Boden is a gorgeous choice. It’s currently reduced from £120 to £66, so now might be ...

A phase 3 trial of Sanofi’s eczema prospect amlitelimab has hit its primary and key secondary endpoints. Yet, with the data falling short of analyst expectations, shares in the company opened down 9% ...

LONDON (Reuters) -Shares in French drugmaker Sanofi fell more than 10% on Thursday, wiping nearly $13 billion off its market value, after late-stage trial data for its experimental inflammatory ...

Investing.com -- Sanofi ’s experimental drug amlitelimab successfully met all primary endpoints in a Phase 3 clinical trial involving adolescent and adult patients with eczema, also known as atopic ...

Sanofi SAN0.68%increase; green up pointing triangle shares plunged at the market open Thursday as results from a late-stage trial of its experimental drug to treat skin conditions disappointed ...

Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.45. Sanofi shares slid Thursday after the company reported underwhelming ...